Back to UVC360

Candida auris (C. auris) is an emerging fungus that presents a serious global health threat. It is a type of yeast that can cause severe illness and spreads easily. The Centers for Disease Control (CDC) is concerned about C. auris for three main reasons:
  1. It is often multidrug-resistant, meaning that it is resistant to multiple antifungal drugs commonly used to treat Candida.  Some strains are resistant to all three available classes of antifungals.
  2. It is difficult to identify with standard laboratory methods, and it can be misidentified in labs without specific technology. Misidentification may lead to inappropriate management.
  3. It has caused outbreaks. For this reason, it is important to quickly identify  C. auris so that facilities can take precautions to stop its spread.1

A layered approach to combatting C. auris

Facilities need multiple layers of defense to ensure the highest level of cleanliness because no single approach can completely eliminate all microorganisms. Tru-D SmartUVC, part of the PDI Healthcare family since 2019, offers a portfolio of products proven to reduce C. auris on hard, nonporous surfaces in environments when combined with EPA-registered disinfection products, such as PDI’s surface disinfectant wipes.

PDI and Tru-D SmartUVC are committed to providing solutions that will help ensure environments are as clean as possible. The Tru-D SmartUVC devices adapt to the needs of a wide range of space types to administer a precise dose of UVC. Using proprietary Sensor360® technology, Tru-D products provide trusted disinfection of hard, nonporous surfaces with remarkable speed and proven efficacy. The Tru-D robots are the only “smart” disinfection solution with Sensor360® technology that measures the reflected UVC energy that bounces back to the robot, allowing the Tru-D devices to provide a precise, lethal dose of UVC needed for thorough room disinfection.

In independent lab testing, the Tru-D iQ devices, both Tower and Scout, have consistently provided thorough room disinfection outcomes including against C. auris. Tower achieved a >4.64 log10 reduction, and Scout achieved a 3.3-3.9 log10 reduction.2

The Tru-D® Classic UVC disinfection device is effective against both C. auris and C. albicans in direct and indirect line of sight, according to a study at the University of North Carolina.3

The Tru-D technology, combined with PDI’s marketing-leading products, including Sani-HyPerCide® Germicidal Disposable Wipe, Sani-Cloth® Prime Germicidal Disposable Wipe and Super Sani-Cloth® Germicidal Disposable Wipe can help rid the health care environment of C. auris.4

References:

  1. https://www.cdc.gov/fungal/candida-auris/index.html
  2. Independent lab testing data on file using Beta version of iQ Tower and iQ Scout.
  3. Rutala WA, Kanamori H, Gergen MF, Sickbert-Bennett EE, Weber DJ. Inactivation of Candida auris and Candida albicans by ultraviolet-C. Infect Control Hosp Epidemiol. 2021;1-3.
  4. Data on file.

 

Categories:

General Disinfection, Layered Approach, PDI, Tru-D News, Tru-D Technology

Tags:

C. auris, Candida auris, PDI Healthcare, Tru-D Classic, Tru-D iQ Scout, Tru-D iQ System, Tru-D iQ Tower

share this article